S1TE34 Stock Overview
Provides infection prevention products and services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
STERIS plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$63.72 |
| 52 Week High | US$67.27 |
| 52 Week Low | US$53.05 |
| Beta | 0.92 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | 14.17% |
| 5 Year Change | n/a |
| Change since IPO | 21.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| S1TE34 | BR Medical Equipment | BR Market | |
|---|---|---|---|
| 7D | 0% | -4.4% | 1.2% |
| 1Y | n/a | 2.0% | -8.4% |
Return vs Industry: Insufficient data to determine how S1TE34 performed against the BR Medical Equipment industry.
Return vs Market: Insufficient data to determine how S1TE34 performed against the BR Market.
Price Volatility
| S1TE34 volatility | |
|---|---|
| S1TE34 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.0% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in BR Market | 9.7% |
| 10% least volatile stocks in BR Market | 3.0% |
Stable Share Price: S1TE34's share price has been volatile over the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine S1TE34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 18,000 | Dan Carestio | www.steris.com |
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services.
STERIS plc Fundamentals Summary
| S1TE34 fundamental statistics | |
|---|---|
| Market cap | R$132.66b |
| Earnings (TTM) | R$3.58b |
| Revenue (TTM) | R$31.32b |
37.1x
P/E Ratio4.2x
P/S RatioIs S1TE34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S1TE34 income statement (TTM) | |
|---|---|
| Revenue | US$5.40b |
| Cost of Revenue | US$3.03b |
| Gross Profit | US$2.37b |
| Other Expenses | US$1.75b |
| Earnings | US$616.59m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.28 |
| Gross Margin | 43.81% |
| Net Profit Margin | 11.42% |
| Debt/Equity Ratio | 33.7% |
How did S1TE34 perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield35%
Payout RatioDoes S1TE34 pay a reliable dividends?
See S1TE34 dividend history and benchmarks| STERIS dividend dates | |
|---|---|
| Ex Dividend Date | Feb 19 2025 |
| Dividend Pay Date | Mar 27 2025 |
| Days until Ex dividend | 20 days |
| Days until Dividend pay date | 16 days |
Does S1TE34 pay a reliable dividends?
See S1TE34 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/10 05:55 |
| End of Day Share Price | 2025/01/20 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
STERIS plc is covered by 25 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Owczarski | Avondale Partners |
| Michael Polark | Baird |
| Erin Wilson Wright | BofA Global Research |